Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 0.00 (-0.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) EV to EBITDA (2015 - 2021)

Updated

Lexicon Pharmaceuticals' EV to EBITDA came in at 13.08 for Q2 2021, compared with 0.23 a year earlier.

Analysis

Lexicon Pharmaceuticals (LXRX) EV to EBITDA (2015 - 2021) Analysis & Trends

Over the trailing twelve months to Jun 30, 2021, Lexicon Pharmaceuticals reported EV to EBITDA of 3.35; for FY2019, it was 1.19.

  • Going back by year, EV to EBITDA was 391.72 in FY2015.
  • The Q2 2021 figure represents the highest quarterly EV to EBITDA since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Lexicon Pharmaceuticals 840.12 Mn 266.67 Mn 653,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 13.08
Jun 30, 2020 0.23
Mar 31, 2020 -0.40
Dec 31, 2019 1.19
Sep 30, 2019 0.13
Dec 31, 2015 391.72
API Access

Lexicon Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=LXRX&period=max&api_key=YOUR_API_KEY